mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-07 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-07 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-07 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
3e-07 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
3e-07 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-07 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
0.28 |
4e-07 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-07 |